{
    "clinical_study": {
        "@rank": "11666", 
        "acronym": "WNJ", 
        "arm_group": {
            "arm_group_label": "wei group and control group", 
            "description": "wei group(n=25) and control group(n=24)"
        }, 
        "biospec_descr": {
            "textblock": "\u2022Patients receiving various types of surgeries under sedation, especially for procedures of\n      colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde\n      cholangiopancreatography (ERCP) cystoscopy and other brief surgeries you are interested in\n      the study."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Testing the efficacy and safety of the WEI Nasal Jet."
        }, 
        "brief_title": "Testing the Efficacy and Safety of the WEI Nasal Jet", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Complication of Surgical Procedure", 
        "detailed_description": {
            "textblock": "This is only initial thought and suggestions from the inventor Dr. Huafeng Wei. Principal\n      investigator from each medical center interested in testing this new device should design\n      their own clinical trials based on patient population and their own ideas for clinical\n      trials. Just remind you that patient safety is number one and try all efforts to minimize\n      patient risks during your clinical study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients receiving various types of surgeries under sedation, especially for\n             procedures of colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde\n             cholangiopancreatography (ERCP) cystoscopy and other brief surgeries you are\n             interested in the study.\n\n        Exclusion Criteria:\n\n          -  Patients with coagulopathy and tendency of nose bleeding.\n\n          -  Patients with any diagnosed cardiac diseases (e.g. cardiac failure, angina, MI,\n             cardiac arrhythmia. etc.)\n\n          -  Patients with any diagnosed pulmonary disease (e.g. asthma, COPD, pulmonary embolism,\n             pulmonary edema etc.)\n\n          -  Pregnant patients\n\n          -  Patients with liver failure\n\n          -  Patients with kidney failure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "58 Years", 
            "minimum_age": "22 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Suggested patient inclusion criteria:\n\n        Patients receiving various types of surgeries under sedation, especially for procedures of\n        colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde\n        cholangiopancreatography (ERCP) cystoscopy and other brief surgeries you are interested in\n        the study."
            }
        }, 
        "enrollment": {
            "#text": "49", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02005406", 
            "org_study_id": "Wei JET"
        }, 
        "intervention": {
            "arm_group_label": "wei group and control group", 
            "description": "JET", 
            "intervention_name": "Experimental group  and control groupl", 
            "intervention_type": "Device", 
            "other_name": [
                "WEI", 
                "Control"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Wei JET", 
        "lastchanged_date": "December 6, 2013", 
        "number_of_groups": "1", 
        "official_title": "Efficacy and Safety of the WEI Nasal Jet", 
        "overall_official": {
            "affiliation": "Shanghai Jiaotong University", 
            "last_name": "Zeyong Yang, MD, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Compare with Control group,there was no significant difference in lowest SaO2 in Wei JET group.", 
            "measure": "lowest SaO2 in Wei JET group", 
            "safety_issue": "Yes", 
            "time_frame": "2 second"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02005406"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fudan University", 
            "investigator_full_name": "Zeyong Yang", 
            "investigator_title": "Shanghai Jiaotong  University", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Fudan University", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Pennsylvania", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Zeyong Yang", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "December 2013"
    }
}